These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9614382

  • 21. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H.
    Cancer Res; 1993 Sep 15; 53(18):4197-203. PubMed ID: 7689929
    [Abstract] [Full Text] [Related]

  • 22. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM, Givehchian M, Dürst M, Schneider A, Costa S, Melsheimer P, Lacroix J, Zöller M, Doeberitz MK.
    Clin Cancer Res; 1995 Oct 15; 1(10):1125-32. PubMed ID: 9815903
    [Abstract] [Full Text] [Related]

  • 23. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
    Kryworuchko M, Diaz-Mitoma F, Kumar A.
    Exp Cell Res; 1999 Jul 10; 250(1):241-52. PubMed ID: 10388538
    [Abstract] [Full Text] [Related]

  • 24. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ, Rustgi AK.
    Cancer Res; 1995 May 01; 55(9):1831-5. PubMed ID: 7537174
    [Abstract] [Full Text] [Related]

  • 25. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A, Purnell P, Nguyen L.
    Exp Mol Pathol; 2009 Apr 01; 86(2):95-100. PubMed ID: 19167378
    [Abstract] [Full Text] [Related]

  • 26. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
    Takahashi K, Stamenkovic I, Cutler M, Saya H, Tanabe KK.
    Oncogene; 1995 Dec 07; 11(11):2223-32. PubMed ID: 8570172
    [Abstract] [Full Text] [Related]

  • 27. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN, Mirejovský T, Melinová L, Mandys V.
    Neoplasma; 2000 Dec 07; 47(6):400-8. PubMed ID: 11263866
    [Abstract] [Full Text] [Related]

  • 28. Two different functions for CD44 proteins in human myelopoiesis.
    Moll J, Khaldoyanidi S, Sleeman JP, Achtnich M, Preuss I, Ponta H, Herrlich P.
    J Clin Invest; 1998 Sep 01; 102(5):1024-34. PubMed ID: 9727071
    [Abstract] [Full Text] [Related]

  • 29. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T, Sleeman JP, Schempp CM, Howells N, Hofmann M, Ponta H, Herrlich P, Simon JC.
    Oncogene; 2001 Jun 07; 20(26):3399-408. PubMed ID: 11423990
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
    Stachura J, Krzeszowiak A, Popiela T, Urbańczyk K, Pituch-Noworolska A, Wieckiewicz J, Zembala M.
    Pol J Pathol; 1999 Jun 07; 50(3):155-61. PubMed ID: 10624117
    [Abstract] [Full Text] [Related]

  • 35. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P, Marhaba R, Jung T, Kirmse R, Ludwig T, Zöller M.
    Mol Cancer Res; 2009 Feb 07; 7(2):168-79. PubMed ID: 19208744
    [Abstract] [Full Text] [Related]

  • 36. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V, Kern HF, Elsässer HP.
    Clin Cancer Res; 1996 Sep 07; 2(9):1607-18. PubMed ID: 9816340
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M, Cicchini C, Giarnieri E, Stazi A, Mingazzini PL, Stipa V.
    Oncol Rep; 2003 Sep 07; 10(6):1875-7. PubMed ID: 14534711
    [Abstract] [Full Text] [Related]

  • 38. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin.
    Aho R, Kalimo H, Salmi M, Smith D, Jalkanen S.
    J Neuropathol Exp Neurol; 1997 May 07; 56(5):557-68. PubMed ID: 9143269
    [Abstract] [Full Text] [Related]

  • 39. Expression of CD44 variant isoforms in malignant melanoma.
    Seiter S, Schadendorf D, Herrmann K, Schneider M, Rösel M, Arch R, Tilgen W, Zöller M.
    Clin Cancer Res; 1996 Mar 07; 2(3):447-56. PubMed ID: 9816190
    [Abstract] [Full Text] [Related]

  • 40. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
    Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R.
    Cancer Res; 2005 Jul 01; 65(13):5812-7. PubMed ID: 15994957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.